Correlation Between Orsted AS and Genmab AS

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Orsted AS and Genmab AS at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Orsted AS and Genmab AS into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Orsted AS and Genmab AS, you can compare the effects of market volatilities on Orsted AS and Genmab AS and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Orsted AS with a short position of Genmab AS. Check out your portfolio center. Please also check ongoing floating volatility patterns of Orsted AS and Genmab AS.

Diversification Opportunities for Orsted AS and Genmab AS

0.33
  Correlation Coefficient

Weak diversification

The 3 months correlation between Orsted and Genmab is 0.33. Overlapping area represents the amount of risk that can be diversified away by holding Orsted AS and Genmab AS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Genmab AS and Orsted AS is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Orsted AS are associated (or correlated) with Genmab AS. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Genmab AS has no effect on the direction of Orsted AS i.e., Orsted AS and Genmab AS go up and down completely randomly.

Pair Corralation between Orsted AS and Genmab AS

Assuming the 90 days trading horizon Orsted AS is expected to under-perform the Genmab AS. In addition to that, Orsted AS is 1.19 times more volatile than Genmab AS. It trades about -0.1 of its total potential returns per unit of risk. Genmab AS is currently generating about 0.04 per unit of volatility. If you would invest  155,150  in Genmab AS on December 2, 2024 and sell it today you would earn a total of  5,700  from holding Genmab AS or generate 3.67% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Orsted AS  vs.  Genmab AS

 Performance 
       Timeline  
Orsted AS 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Orsted AS has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Genmab AS 

Risk-Adjusted Performance

Weak

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Genmab AS are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy basic indicators, Genmab AS is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.

Orsted AS and Genmab AS Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Orsted AS and Genmab AS

The main advantage of trading using opposite Orsted AS and Genmab AS positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Orsted AS position performs unexpectedly, Genmab AS can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Genmab AS will offset losses from the drop in Genmab AS's long position.
The idea behind Orsted AS and Genmab AS pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.

Other Complementary Tools

Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules